Innovations in Virtual Drug Screening - Cerebras

This post details how Cerebras CS-2 systems accelerate virtual drug screening by over 50x, reducing screening time from 183 days to 3.5 days. It explains that traditional GPUs are inefficient for the small, fully connected models used in drug screening due to low utilization and memory bottlenecks. The Cerebras WSE architecture, with its 850,000 AI-optimized cores, high-speed memory, and low-latency fabric, allows for efficient mapping and distribution of computations for multiple copies of these small models, achieving massive inference acceleration and high throughput.